Chemcel Biotech Ltd
Chemcel Biotech Limited is an India-based company, which is a manufacturer of agro chemicals, such as insecticides, fungicides and plant growth promoters.
- Market Cap ₹ Cr.
- Current Price ₹ 0.95
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 15.7
- Dividend Yield 0.00 %
- ROCE -0.70 %
- ROE -0.86 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.06 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -14.4% over past five years.
- Company might be capitalizing the interest cost
- Company has high debtors of 1,132 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|
| 18.58 | 21.45 | 23.45 | 31.41 | 42.32 | 47.67 | 17.97 | 14.48 | |
| 17.15 | 19.18 | 20.55 | 28.36 | 39.39 | 45.20 | 19.18 | 14.81 | |
| Operating Profit | 1.43 | 2.27 | 2.90 | 3.05 | 2.93 | 2.47 | -1.21 | -0.33 |
| OPM % | 7.70% | 10.58% | 12.37% | 9.71% | 6.92% | 5.18% | -6.73% | -2.28% |
| 0.08 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.89 | 0.00 | |
| Interest | 0.48 | 0.70 | 1.14 | 1.20 | 1.06 | 1.24 | 0.00 | 0.00 |
| Depreciation | 0.13 | 0.12 | 0.11 | 0.10 | 0.09 | 0.08 | 0.06 | 0.05 |
| Profit before tax | 0.90 | 1.46 | 1.65 | 1.75 | 1.78 | 1.15 | -0.38 | -0.38 |
| Tax % | 22.22% | 35.62% | 25.45% | 25.14% | 23.03% | 24.35% | 0.00% | 0.00% |
| 0.70 | 0.94 | 1.23 | 1.31 | 1.37 | 0.87 | -0.37 | -0.38 | |
| EPS in Rs | 0.51 | 0.53 | 0.31 | -0.13 | -0.14 | |||
| Dividend Payout % | 95.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -14% |
| 3 Years: | -33% |
| TTM: | -19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | -1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.65 | 10.52 | 10.52 | 25.92 | 25.92 | 27.92 | 27.92 | 27.92 |
| Reserves | 0.46 | 1.56 | 2.78 | 13.13 | 14.66 | 16.52 | 16.27 | 15.89 |
| 9.17 | 6.54 | 7.02 | 5.05 | 9.59 | 10.07 | 10.63 | 10.58 | |
| 3.22 | 6.28 | 7.99 | 3.03 | 5.72 | 5.60 | 13.00 | 17.78 | |
| Total Liabilities | 19.50 | 24.90 | 28.31 | 47.13 | 55.89 | 60.11 | 67.82 | 72.17 |
| 1.10 | 0.99 | 1.29 | 1.23 | 1.15 | 1.07 | 0.94 | 0.89 | |
| CWIP | 5.80 | 0.13 | 0.00 | 7.37 | 7.37 | 7.37 | 7.37 | 7.37 |
| Investments | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | 0.00 |
| 12.60 | 23.78 | 26.99 | 38.50 | 47.34 | 51.64 | 59.51 | 63.91 | |
| Total Assets | 19.50 | 24.90 | 28.31 | 47.13 | 55.89 | 60.11 | 67.82 | 72.17 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|
| -5.68 | -6.48 | -14.08 | -4.98 | -3.76 | 0.08 | -0.13 | ||
| -5.79 | 5.65 | -8.67 | 0.25 | 0.25 | 0.03 | 0.00 | ||
| 11.45 | 0.84 | 22.68 | 4.69 | 3.48 | -0.10 | 0.19 | ||
| Net Cash Flow | -0.02 | 0.01 | -0.07 | -0.04 | -0.03 | 0.01 | 0.06 | |
| Free Cash Flow | -11.48 | -0.83 | -21.48 | -4.98 | -3.76 | 0.08 | -0.13 | |
| CFO/OP | -397% | -285% | -447% | -170% | -141% | -7% | 39% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 129.66 | 180.88 | 175.26 | 277.15 | 208.89 | 248.08 | 839.68 | 1,132.05 |
| Inventory Days | 46.80 | 48.17 | 45.53 | 80.07 | 101.99 | |||
| Days Payable | 14.76 | 31.50 | 12.20 | 182.92 | 365.82 | |||
| Cash Conversion Cycle | 129.66 | 180.88 | 175.26 | 309.19 | 225.57 | 281.41 | 736.83 | 868.23 |
| Working Capital Days | 183.48 | 297.28 | 293.40 | 396.61 | 349.91 | 346.70 | 855.93 | 1,063.49 |
| ROCE % | 12.38% | 14.33% | 9.16% | 6.03% | 4.57% | -0.70% |
Documents
Announcements
No data available.